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sive drugs, patients would be expected to have filled med-
ications documented in medical records within the “filled
as intended” time frame. This simple analysis further il-
lustrates that patients frequently do not comply with med-
ication taking for chronic, asymptomatic conditions.
TPCP3
PATIENT COMPLIANCE, QUALITY OF LIFE, AND 
SATISFACTION AFTER INTENSIVE 
OUTPATIENT COUNSELING
Juzba M, Hay J
University of Southern California School of Pharmacy, 
Department of Pharmaceutical Economics and Policy, Los 
Angeles, CA, USA
OBJECTIVE: The purpose of this study was to determine
the impact on quality of life, level of compliance and sat-
isfaction with services after pharmacist outpatient coun-
seling and monitoring.
METHOD: The study is a prospective examination of hy-
pertensive patients over 64 years old. The control group
(N  160) received standard drug counseling on receiv-
ing new medication. The treatment group (N  144) re-
ceived extensive drug education and monthly follow-up
calls for reassessment and to reinforcing compliance. The
patients filled out health status surveys at the start of the
study (T0), in 6 months (T1) and 12 months later (T2). The
survey instruments included Pharmacy Services satisfac-
tion, the Morisky Compliance Scale, medication aware-
ness, smoking, liquor, Likert Scale self-assessment of glo-
bal health (0–100 in 10-unit decrements), SF-36, HUI
Mark 2, and the Hypertension/Lipid TyPE Survey.
RESULTS: The groups were compared to each other at T0
and T2, and compared to themselves from T0 to T2. The
difference between groups in Morisky Score and Likert
Scale was not significant and neither group had significant
changes. At T2 the treatment group had a higher SF-36 RE
score than the control group, 79.06 versus 67.42 (p 
0.05) while other scales showed no significant differences
between groups or changes over time. The difference be-
tween groups in HUI attributes or utility score was not sig-
nificant and neither group had significant changes.
CONCLUSION: Patient counseling does not appear to
enhance compliance in this population. QoL scores indi-
cate some emotional benefit, possibly due to ongoing
pharmacist contact. Other measures in this population
suggest no impact on overall level of health based on out-
patient counseling.
TPCP4
DISCRETE CHOICE MODELING ON PATIENT 
PERCEIVED COMPLIANCE: ANALYSIS OF 
PATIENT’S HEALTH BELIEF PERSPECTIVE
Sengupta N, Nichol MB, Cattaneo M
Department of Pharmaceutical Economics and Policy, 
University of Southern California, Los Angeles, CA, USA
Patient compliance with their medication regimen is es-
sential for the success of their medical therapy, especially
in the treatment of chronic illnesses.
OBJECTIVE: The purpose of the present study is to iden-
tify factors that influence patient perceived compliance in
accordance to patient’s health belief perspective.
METHOD: This study employed a stratified random sam-
ple of 7000 patients from southern California, served by a
large health maintenance organization (Kaiser Perma-
nente). The dependent variable was derived from a well-
validated self-reported (Morisky) scale for patient adher-
ence in medication regimen. First a restrictive binary
choice logistic model was made where patients were differ-
entiated on basis of their compliance or noncompliance.
Next, patient’s compliance behavior was categorized as
High, Medium, or Low, and an ordered probit model was
employed. Patient’s socioeconomic status, comorbidities,
prescription utilization pattern were used as explanatory
variables.
RESULTS: The study sample consisted of patients 34 to 82
years of age (mean  50). Both restrictive and relaxed
models showed that likelihood of poor or medium compli-
ance significantly (p  0.0001) increased with age. Female
patients, African Americans, and employed persons were
likely to have more compliant behavior. Patient health be-
haviors (smoking, drinking) or education did not show any
significant contribution to prediction. Patients with high
physical or mental SF-36 component scores and fewer
chronic diseases were found poorly compliant. Model
fit was evaluated by adjusted generalized R2 (0.1348) as
well as by ROC curves (sensitivity [25.7%] and specific-
ity [99.5%]).
CONCLUSION: Findings of this study reconfirmed the
usefulness of the health belief model in determining fac-
tors affecting compliance.
TPCP5
THE COST OF DISCONTINUATION OF
ANTI-HYPERTENSIVE DRUG THERAPY IN A 
MEDICAID POPULATION
Venturini F1, Nichol MB1, McCombs JS1, Sengupta N1, 
Kamath T1, Tannous RE2
1University of Southern California, Los Angeles, CA, USA, 
2PrudentRx, Culver City, CA, USA
The majority of diagnosed hypertensive patients receive
drug therapy in addition to recommended lifestyle changes.
One of the major barriers to the management of hyper-
tension is the interruption or premature termination of
therapy.
OBJECTIVE: To estimate the prevalence of, and health-
care costs associated with, the discontinuation of anti-
hypertensive drug therapy in a Medi-Cal population.
METHODS: The Medi-Cal paid claims data were used
to identify patients with at least one anti-hypertensive
prescription. The date of this first prescription was used
to partition the patient’s stream of paid claims into pre-
and post-time periods of 6 and 12 months, respectively.
